Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit

NARecruitingINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

December 31, 2026

Conditions
Motor DelayPremature BirthIntraventricular HemorrhageHypoxic-Ischemic EncephalopathyBronchopulmonary Dysplasia
Interventions
OTHER

Physical Therapy intervention

The intervention is based on five principles: active learning, caregiver engagement, environmental enrichment, strengths-based approach, and dose. The intervention will start in the NICU and continue until 12-months corrected age. Infants in the intervention group will receive up to two therapist visits per week in addition to standard of care physical therapy. Caregivers will be asked to work with their infant on activities provided by the therapist. The therapist will provide resources to support the caregiver in working on these activities with their child, and caregivers will be asked to complete the activities for as much time as possible, throughout the day. Therapists will work with caregivers to identify ways to incorporate activities into their day. Caregiver engagement and caregiver ability to complete sessions and activity recommendations will be monitored.

Trial Locations (3)

60611

RECRUITING

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

RECRUITING

Northwestern Medicine Prentice Children's Hospital, Chicago

60612

RECRUITING

Children's Hospital at the University of Illinois, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

collaborator

Northwestern University

OTHER

collaborator

Northwestern Medicine

OTHER

collaborator

University of Illinois at Chicago

OTHER

lead

Shirley Ryan AbilityLab

OTHER

NCT05568264 - Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit | Biotech Hunter | Biotech Hunter